Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proliferation-associated 2G4 pseudogene 1 (PA2G4P1) is a human processed pseudogene within the PA2G4 gene family[3]. Unlike its functional counterpart (PA2G4, also known as ErbB3-binding protein 1/EBP1), which encodes an RNA-binding protein involved in growth regulation and is implicated in tumorigenesis, PA2G4P1 does not encode a functional protein and is not a conventional therapeutic or diagnostic target[1][5]. Several pseudogenes of PA2G4 exist (on chromosomes 3, 6, 9, 18, 20, and X)[1]. Some, most notably PA2G4P4, have been found to be transcriptionally active and may play regulatory roles in cancer by affecting cell proliferation, migration, and survival — especially in bladder cancer[2][4]. However, PA2G4P1 specifically has not yet been implicated in these functions or as a validated molecular target. For therapeutic and clinical research purposes, references to *functional* PA2G4 or even PA2G4 pseudogenes as drug targets should be checked for correct gene/pseudogene identity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proliferation-associated 2G4 pseudogene 1 (PA2G4P1).